At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)

At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)

Conditions: Diabetes Mellitus, Type 1
Interventions: Biological: teplizumab
Sponsors: Provention Bio, Inc.
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 30, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments